Relationship between nitric oxide production and choroidal blood flow

Area of Science:

• Ophthalmology
• Pharmacology
• Vascular Biology

Background:

• Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly.
• Choroidal neovascularization is a key pathological feature of AMD.
• Modulating ocular blood flow is a potential therapeutic strategy for AMD.

Purpose of the Study:

• To develop a drug that specifically enhances choroidal blood flow through nitric oxide (NO) production.
• To investigate the efficacy of novel thiourea derivatives as potential treatments for AMD.

Main Methods:

• In vitro studies using cell cultures to assess NO production by NO donors.
• In vivo experiments utilizing the colored microsphere technique to measure blood flow in rabbit ocular tissues.
• Chemical synthesis and characterization of ZX-5 (trans-isomer) and ZX-4 (cis-isomer).

Main Results:

• ZX-5 demonstrated significant NO release at concentrations of 3, 10, and 30 microg/ml.
• Topical instillation of ZX-5 (1%, 50 microl) specifically increased choroid blood flow in rabbit eyes.
• ZX-5 showed no effect on iris or ciliary body blood flow, while its isomer ZX-4 was ineffective.
• ZX-4 did not release NO and had no impact on ocular blood flow.

Conclusions:

• ZX-5 selectively increases choroidal blood flow, suggesting potential therapeutic value in suppressing choroidal neovascularization.
• ZX-5 represents a promising candidate for the treatment or prevention of AMD in elderly populations.
• Further research into ZX-5 and related compounds may lead to novel therapeutic interventions for AMD.